» Articles » PMID: 21849433

Antigen-dependent and -independent Mechanisms of T and B Cell Hyperactivation During Chronic HIV-1 Infection

Overview
Journal J Virol
Date 2011 Aug 19
PMID 21849433
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Continuous loss of CD4(+) T lymphocytes and systemic immune activation are hallmarks of untreated chronic HIV-1 infection. Chronic immune activation during HIV-1 infection is characterized by increased expression of activation markers on T cells, elevated levels of proinflammatory cytokines, and B cell hyperactivation together with hypergammaglobulinemia. Importantly, hyperactivation of T cells is one of the best predictive markers for progression toward AIDS, and it is closely linked to CD4(+) T cell depletion and sustained viral replication. Aberrant activation of T cells is observed mainly for memory CD4(+) and CD8(+) T cells and is documented, in addition to increased expression of surface activation markers, by increased cell cycling and apoptosis. Notably, the majority of these activated T cells are neither HIV specific nor HIV infected, and the antigen specificities of hyperactivated T cells are largely unknown, as are the exact mechanisms driving their activation. B cells are also severely affected by HIV-1 infection, which is manifested by major changes in B cell subpopulations, B cell hyperactivation, and hypergammaglobulinemia. Similar to those of T cells, the mechanisms underlying this aberrant B cell activation remain largely unknown. In this review, we summarized current knowledge about proposed antigen-dependent and -independent mechanisms leading to lymphocyte hyperactivation in the context of HIV-1 infection.

Citing Articles

CBP/p300 lysine acetyltransferases inhibit HIV-1 expression in latently infected T cells.

Horvath R, Sadowski I iScience. 2024; 27(12):111244.

PMID: 39640574 PMC: 11617383. DOI: 10.1016/j.isci.2024.111244.


HIV-1 Infection Results in Sphingosine-1-Phosphate Receptor 1 Dysregulation in the Human Thymus.

Resop R, Salvatore B, Kim S, Gordon B, Blom B, Vatakis D Int J Mol Sci. 2023; 24(18).

PMID: 37762169 PMC: 10531245. DOI: 10.3390/ijms241813865.


Analysis of SARS-CoV-2 isolates, namely the Wuhan strain, Delta variant, and Omicron variant, identifies differential immune profiles.

Shahbaz S, Bozorgmehr N, Lu J, Osman M, Sligl W, Tyrrell D Microbiol Spectr. 2023; :e0125623.

PMID: 37676005 PMC: 10581158. DOI: 10.1128/spectrum.01256-23.


Clinicopathological and Epidemiological Findings in Pet Cats Naturally Infected with Feline Immunodeficiency Virus (FIV) in Australia.

Carlton C, Norris J, Hall E, Ward M, Blank S, Gilmore S Viruses. 2022; 14(10).

PMID: 36298731 PMC: 9608632. DOI: 10.3390/v14102177.


Activated-memory T cells influence naïve T cell fate: a noncytotoxic function of human CD8 T cells.

Sasaki K, Moussawy M, Abou-Daya K, Macedo C, Hosni-Ahmed A, Liu S Commun Biol. 2022; 5(1):634.

PMID: 35768564 PMC: 9243096. DOI: 10.1038/s42003-022-03596-2.


References
1.
Brenchley J, Price D, Schacker T, Asher T, Silvestri G, Rao S . Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006; 12(12):1365-71. DOI: 10.1038/nm1511. View

2.
Funderburg N, Luciano A, Jiang W, Rodriguez B, Sieg S, Lederman M . Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PLoS One. 2008; 3(4):e1915. PMC: 2271052. DOI: 10.1371/journal.pone.0001915. View

3.
Fry T, Mackall C . Interleukin-7: master regulator of peripheral T-cell homeostasis?. Trends Immunol. 2001; 22(10):564-71. DOI: 10.1016/s1471-4906(01)02028-2. View

4.
Bucy R, Hockett R, Derdeyn C, Saag M, Squires K, Sillers M . Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest. 1999; 103(10):1391-8. PMC: 408455. DOI: 10.1172/JCI5863. View

5.
Quaranta M, Camponeschi B, Straface E, Malorni W, Viora M . Induction of interleukin-15 production by HIV-1 nef protein: a role in the proliferation of uninfected cells. Exp Cell Res. 1999; 250(1):112-21. DOI: 10.1006/excr.1999.4494. View